Article in Journal of adolescent and young adult oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 6 institutions in 1 country.
Amisha SinghDepartment of Internal Medicine, University of California Davis School of Medicine, Sacramento, California, USA.ORCID 0000-0001-9094-7385
Steven ThorpeDepartment of Orthopedic Surgery, University of California, Davis Comprehensive Cancer Center, Orange, California, USA.
Theresa KeeganDivision of Hematology and Oncology, University of California, Davis Comprehensive Cancer Center, Sacramento, California, USA.
Frances MaguireCalifornia Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento, California, USA.
Marcio MalogolowkinDivision of Pediatric Hematology/Oncology, University of California Davis School of Medicine, Sacramento, California, USA.
Renata AbrahãoCenter for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis, Sacramento, California, USA.
Sheri SpuntPediatric Hematology/Oncology, Stanford University School of Medicine, Palo Alto, California, USA.
Janai Carr-AsherDivision of Hematology and Oncology, University of California, Davis Comprehensive Cancer Center, Sacramento, California, USA.
Elysia AlvarezDivision of Pediatric Hematology/Oncology, University of California Davis School of Medicine, Sacramento, California, USA.ORCID 0000-0002-1615-2848
University of California, Davis · USUniversity of California Davis Medical Center · USCenter For Policy Research · USStanford University · USUC Davis Comprehensive Cancer CenterUniversity of California, Irvine Medical Center · US
Funding
Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development ProgramK12CA138464 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BIRKELAND, ANDREW CHARLES, LARA, PRIMO N. · 2011 to 2025
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Localized Synovial Sarcoma: A Population-Based Analysis of Treatment Patterns and Survival. · full record | OpenQuestion